Kenneth C. Cundy - 09 Dec 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Scientific Officer
Signature
/s/ Kenneth C. Cundy
Issuer symbol
ANEB
Transactions as of
09 Dec 2022
Net transactions value
$0
Form type
4
Filing time
13 Dec 2022, 20:19:50 UTC
Previous filing
07 Jun 2022
Next filing
08 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +35,017 $0.000000 35,017 09 Dec 2022 Common Stock 35,017 $3.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter first occurring after December 9, 2022.